Pharmacokinetics and toxicity of repeated oral etoposide is altered by morphine coadministration in rats

Makoto Miyazaki1, Tomoko Kawase, Chisako Nishimura

  • 1Department of Pharmaceutics, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan, miyazaki@gly.oups.ac.jp.

Insights

Morphine (MOR) coadministration alters etoposide (ETP) absorption and toxicity in rats. MOR prolonged ETP-induced leukocyte reduction and decreased animal survival, indicating significant pharmacokinetic and toxicological interactions.

Area of Science:

  • Pharmacology
  • Toxicology
  • Drug Interactions

Background:

  • Etoposide (ETP) is a chemotherapy agent with variable oral absorption.
  • Morphine (MOR) is an opioid analgesic with potential to affect drug metabolism and transport.

Purpose of the Study:

  • To investigate the influence of repeated oral morphine (MOR) on the pharmacokinetics and toxicity of etoposide (ETP) in rats.
  • To elucidate the mechanisms underlying ETP-MOR interactions, potentially involving P-glycoprotein (P-gp).

Main Methods:

  • Rats received daily oral etoposide (ETP) with or without morphine (MOR) for a defined period.
  • Plasma ETP concentrations were measured to estimate pharmacokinetic parameters using Bayesian analysis and a 2-compartment model.
  • Leukocyte counts and animal viability were monitored to assess toxicity.

Main Results:

  • Morphine (MOR) coadministration prolonged ETP-induced leukopenia and decreased animal viability.
  • Repeated ETP dosing with MOR resulted in higher trough ETP concentrations and prolonged exposure compared to ETP alone.
  • MOR altered ETP's intestinal absorption rate and bioavailability, suggesting involvement of P-glycoprotein (P-gp).

Conclusions:

  • Repeated oral coadministration of morphine (MOR) significantly alters the pharmacokinetics and enhances the toxicity of etoposide (ETP) in rats.
  • These interactions are likely mediated by changes in ETP's intestinal absorption, potentially via P-glycoprotein (P-gp) modulation.
  • Clinicians should consider potential drug interactions when co-prescribing MOR and ETP, especially with oral administration.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
419
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
525
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.6K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
502
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
122